Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) Technology appraisal guidance [TA240] – NICE

NICE is unable to recommend panitumumab with 5‑fluorouracil, folinic acid and irinotecan (FOLFIRI) for previously treated metastatic colorectal cancer in adults because no evidence submission was received from the manufacturer or sponsor of the technology.

Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal): Technology appraisal guidance [TA438] – NICE

NICE is unable to make a recommendation about the use in the NHS of alectinib for anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer previously treated with crizotinib because no evidence submission was received from Roche. We will review this decision

Cetuximab and panitumumab for previously untreated metastatic colorectal cancer: Technology appraisal guidance [TA439] – NICE

Evidence-based recommendations on cetuximab (Erbitux) and panitumumab (Vectibix) for previously untreated RAS wild-type metastatic colorectal cancer in adults. This guidance replaces NICE technology appraisal guidance on cetuximab for the first-line treatment of metastatic colorectal cancer (TA176). This guidance partially updates

Sugar Reduction: Achieving the 20%: A technical report outlining progress to date, guidelines for industry, 2015 baseline levels in key foods and next steps – Public Health England

This report sets out guidelines for all sectors of the food industry on how to achieve a 20% sugar reduction across the top 9 categories of food that contribute most to intakes of children up to the age of 18

Public satisfaction with the NHS and social care in 2016: Results and trends from the British Social Attitudes survey – King’s Fund

The British public’s satisfaction with the NHS remained steady in 2016, according to the data contained in this report. The findings from the British Social Attitudes survey, carried out by the National Centre for Social Research between July and October

NHS Women On Boards: 50:50 By 2020 – NHS Employers

This report examines the steps the NHS needs to take to reach the target of equal gender representation on boards by 2020. It summarises demographic data from 452 organisations, including arms-length bodies, NHS trusts and clinical commissioning groups. It has

Improving accountability in the provision of new models of care: Winter Review Report – National Association of Primary Care

Report focused on population budgets and new metrics for new models of care particularly in relation to the Primary Care Home. Population budgets start from the premise that the patient populations determine what services are needed and how those services are

Skills for Health working paper 2: How we can act now to create a high quality support workforce in the UK’s health sector – Skills for Health

Paper that argues whilst the support workforce requires more skills development, this development needs to be an integral part of an organisation’s workforce development strategy and be accompanied by the development of high quality roles. Using skills that have been

The Healthcare Support Workforce: A case for ongoing development and investment – Skills for Health

This report highlights the broad range of roles that support workers are involved in helping clinicians undertake their jobs effectively and being an integral part of the clinical team. We explore the characteristics of those roles that are both directly

Integration and the development of the workforce: Skills for Health Working Paper – Skills for Health

This paper is a reflection of the lessons Skills for Health have learned so far in developing a workforce to meet the integration, it identifies: One of the most profound areas for the transformation of the workforce is that of shifting

Statutory Homelessness in England: (Briefing paper SN01164) – House of Commons Library

This House of Commons Library briefing paper provides statistics on statutory homelessness in England and explains local authorities’ duties to assist homeless households. The paper includes an overview of, and comment on, Government policy in this area. Additional Item

Ibrutinib with bendamustine and rituximab for treating relapsed or refractory chronic lymphocytic leukaemia after systemic therapy (terminated appraisal): Technology appraisal guidance [TA437] – NICE

NICE was unable to make a recommendation about the use in the NHS of ibrutinib with bendamustine and rituximab for treating relapsed or refractory chronic lymphocytic leukaemia after systemic therapy because no evidence submission was received from Janssen-Cilag, but will

Bevacizumab for treating EGFR mutation-positive non-small-cell lung cancer (terminated appraisal): Technology appraisal guidance [TA436] – NICE

NICE was unable to make a recommendation about the use in the NHS of bevacizumab for treating epidermal growth factor receptor mutation-positive non-small-cell lung cancer because no evidence submission was received from Roche, but will review this decision if the

Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal): Technology appraisal guidance [TA435] – NICE

NICE was unable to make a recommendation about the use in the NHS of tenofovir alafenamide for treating chronic hepatitis B because no evidence submission was received from Gilead, but will review this decision if the company decides to make a

Elotuzumab for previously treated multiple myeloma (terminated appraisal): Technology appraisal guidance [TA434] – NICE

NICE was unable to make a recommendation about the use in the NHS of elotuzumab for previously treated multiple myeloma because no evidence submission was received from Bristol–Myers Squibb, but will review this decision if the company decides to make

Sacrocolpopexy with hysterectomy using mesh to repair uterine prolapse: Interventional procedures guidance [IPG577] – NICE

Evidence-based recommendations on sacrocolpopexy with hysterectomy using mesh to repair uterine prolapse. This involves attaching mesh from the top of the vagina to the base of the spine to support the pelvic organs after the womb has been removed. This

Extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women: Interventional procedures guidance [IPG576] – NICE

Evidence-based recommendations on extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women. This involves putting 2 small balloons on either side of the tube that carries urine from the bladder to support it and reduce leaks. This guidance

Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer: Clinical guideline [CG164] – NICE

This guideline covers care for people with a family history of breast, ovarian or another related (prostate or pancreatic) cancer. It aims to improve the long-term health of these families by describing strategies to reduce the risk of and promote